NASDAQ · Biotechnology

Immunitybio Inc (IBRX)

$7.79 -0.64%

Add alert

53 In band Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$6.06+28.55%

Company profile

ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy.

SectorHealthcare

IndustryBiotechnology

Market cap$7.94B

P/E ratioNone

EPS$-0.93

Beta0.125

Dividend yield0.00%

52-week high$12.43

52-week low$1.95

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 79 VRTX Vertex Pharmaceuticals Inc RSI 67 CRSP CRISPR Therapeutics AG RSI 67 IOVA Iovance Biotherapeutics Inc RSI 72 MRNA Moderna Inc RSI 72 VKTX Viking Therapeutics Inc RSI 48 SRPT Sarepta Therapeutics Inc RSI 59 EDIT Editas Medicine Inc RSI 57 NVAX Novavax Inc RSI 63 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 46

Free forever

RSI alerts for IBRX

Get an email the moment Immunitybio Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 12 August 2026 at 9:11 AM EDT